Media and Investors Resources

Minutes of the AGM, 8 June 2022

German version

Press Release, 8 June 2022

Adhoc Press Release

Annual General Meeting of Kuros Biosciences approves all resolutions

Press Release, 2 June 2022

Adhoc Press Release

Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment

Press Release, 31 May 2022

Kuros Biosciences announces favorable preliminary results of MagnetOs as standalone alternative to autograft in first randomized controlled trial

Press Release, 18 May 2022

Kuros Biosciences announces commercial launch of MagnetOs Easypack Putty in the U.S.

Press Release, 27 April 2022

Adhoc Press Release

Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft